Collaborate Disseminate
This week, both Moderna and Pfizer announced they have commenced clinical trials testing Omicron-specific formulations of their mRNA COVID-19 vaccines. Data from the trials is expected in the first half of 2022, however, some experts suggest the end of… Continue reading Moderna and Pfizer launch Omicron-specific COVID vaccine trials
New research led by scientists from the University of Cambridge has provided strong evidence that mutations in two key genes known to heighten breast cancer risk can also be linked with increased risk of developing prostate, pancreatic and stomach canc… Continue reading Breast cancer risk genes linked to prostate, pancreatic and stomach cancer
A pair of new studies have homed in on key biomarkers that could help identify, at the point of initial infection, those most at risk of developing long COVID. The studies suggest a combination of immune biomarkers and acute symptoms can be used to pre… Continue reading How to predict who is most likely to develop long COVID
With psychedelics well and truly hitting the mainstream, scientists are finally subjecting many anecdotal claims to the rigors of clinical research. The phenomenon of microdosing is one of those well-known psychedelic practices that many advocates arde… Continue reading No difference between psilocybin microdosing and placebo, trial finds
A small study has built on a growing body of evidence indicating long COVID symptoms may be linked to abnormal immune system activity. The new research found unexpected markers of inflammation in the cerebrospinal fluid of several patients experiencing… Continue reading Post-COVID brain fog linked to immune abnormalities in spinal fluid
A trio of new studies from the Centers for Disease Control and Prevention (CDC) offer the first real-world insights into the effectiveness of a third COVID-19 vaccine dose against the rapidly spreading Omicron variant of SARS-CoV-2. The research confir… Continue reading First US booster data shows 3rd dose crucial against Omicron
A new announcement from vaccine company Valneva indicates its experimental COVID-19 vaccine is effective at neutralizing the Omicron variant. The vaccine is at the tail-end of Phase 3 trials and is the first inactivated whole-virus vaccine to be triale… Continue reading New whole-virus COVID vaccine may be effective against Omicron
A large genetic study tracking 150,000 subjects for over a decade has affirmed the direct causal link between drinking alcohol and developing cancer. The findings particularly link oesophageal cancers and head and neck cancers with alcohol consumption…. Continue reading Alcohol consumption can directly cause cancer, new genetic study finds
A novel study led by researchers from the University of Oxford has investigated the lingering cognitive effects of mild COVID-19 in the months following infection. The research revealed minor deficits in attention and memory can be seen for up to six m… Continue reading Oxford study detects cognitive deficits months after mild COVID
A new study has proposed that a simple retina scan could indicate whether a person is at risk of early death. The research found the greater the gap between a person’s chronological age and retinal age the higher their risk of dying.Continue ReadingCat… Continue reading A simple retina scan could predict your risk of early death